Exendin-4 promotes extracellular-superoxide dismutase expression in A549 cells through DNA demethylation

Journal of Clinical Biochemistry and Nutrition

Volumn 58, Issue 1, 2016, Pages 34-39

  Yasuda, Hiroyuki ^a   Mizukami, Koji ^a   Hayashi, Mutsuna ^a   Kamiya, Tetsuro ^a   Hara, Hirokazu ^a   Adachi, Tetsuo ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

DNA demethylation; Epigenetics; Exendin 4; Extracellular superoxide dismutase

Indexed keywords

AZACITIDINE; COPPER ZINC SUPEROXIDE DISMUTASE; DNA METHYLTRANSFERASE; EXENDIN 4; EXTRACELLULAR SUPEROXIDE DISMUTASE; GENOMIC DNA; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; MANGANESE SUPEROXIDE DISMUTASE;

A549 CELL LINE; ARTICLE; CONTROLLED STUDY; DNA DEMETHYLATION; DNA METHYLATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INACTIVATION; EPIGENETICS; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION;

EID: 84957657688     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.15-16     Document Type: Article

References (32)

1. Cave AC, Brewer AC, Narayanapanicker A, et al. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006; 8: 691-728.
2. Wright E Jr, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract 2006; 60: 308-314.
3. Vachier I, Chanez P, Le Doucen C, Damon M, Descomps B, Godard P. Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients. Eur Respir J 1994; 7: 1585-1592.
4. Ookawara T, Imazeki N, Matsubara O, et al. Tissue distribution of immunoreactive mouse extracellular superoxide dismutase. Am J Physiol 1998; 275 (3 Pt 1): C840-C847.
5. Folz RJ, Guan J, Seldin MF, Oury TD, Enghild JJ, Crapo JD. Mouse extracellular superoxide dismutase: primary structure, tissue-specific gene expression, chromosomal localization, and lung in situ hybridization. Am J Respir Cell Mol Biol 1997; 17: 393-403.
6. Stralin P, Marklund SL. Vasoactive factors and growth factors alter vascular smooth muscle cell EC-SOD expression. Am J Physiol Heart Circ Physiol 2001; 281: H1621-H1629.
7. Heistad DD. Oxidative stress and vascular disease: 2005 Duff lecture. Arterioscler Thromb Vasc Biol 2006; 26: 689-695.
8. Teoh-Fitzgerald ML, Fitzgerald MP, Jensen TJ, Futscher BW, Domann FE. Genetic and epigenetic inactivation of extracellular superoxide dismutase promotes an invasive phenotype in human lung cancer by disrupting ECM homeostasis. Mol Cancer Res 2012; 10: 40-51.
9. Sibenaller ZA, Welsh JL, Du C, et al. Extracellular superoxide dismutase suppresses hypoxia-inducible factor-1α in pancreatic cancer. Free Radic Biol Med 2014; 69: 357-366.
10. Kristensen LS, Nielsen HM, Hansen LL. Epigenetics and cancer treatment. Eur J Pharmacol 2009; 625: 131-142.
11. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007; 447: 425-432.
12. Illingworth RS, Bird AP. CpG islands-'a rough guide'. FEBS Lett 2009; 583: 1713-1720.
13. Chatterjee R, Vinson C. CpG methylation recruits sequence specific transcription factors essential for tissue specific gene expression. Biochim Biophys Acta 2012; 1819: 763-770.
14. Pellacani D, Kestoras D, Droop AP, et al. DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation. Cell Death Differ 2014; 21: 761-773.
15. Chen T, Li E. Structure and function of eukaryotic DNA methyltransferase. Curr Top Dev Biol 2004; 60: 55-89.
16. Jones PA, Liang G. Rethinking how DNA methylation patterns are maintained. Nat Rev Genet 2009; 10: 805-811.
17. Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD; Exenatide-113 Clinical Study Group. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care 2004; 27: 2628-2635.
18. Thorens B, Porret A, Bühler L, Deng SP, Morel P, Widmann C. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes 1993; 42: 1678-1682.
19. Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. Circulation 2008; 117: 2340-2350.
20. Fattman CL, Schaefer LM, Oury TD. Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med 2003; 35: 236-256.
21. Adachi T, Inoue M, Hara H, Maehata E, Suzuki S. Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients. J Endocrinol 2004; 181: 413-417.
22. Fujita H, Fujishima H, Chida S, et al. Reduction of renal superoxide dismutase in progressive diabetic nephropathy. J Am Soc Nephrol 2009; 20: 1303-1313.
23. Call JA, Chain KH, Martin KS, et al. Enhanced skeletal muscle expression of extracellular superoxide dismutase mitigates streptozotocin-induced diabetic cardiomyopathy by reducing oxidative stress and aberrant cell signaling. Circ Heart Fail 2015; 8: 188-197.
24. Zelko IN, Mueller MR, Folz RJ. CpG methylation attenuates Sp1 and Sp3 binding to the human extracellular superoxide dismutase promoter and regulates its cell-specific expression. Free Radic Biol Med 2010; 48: 895-904.
25. Zelko IN, Mueller MR, Folz RJ. Transcription factors Sp1 and Sp3 regulate expression of human extracellular superoxide dismutase in lung fibroblasts. Am J Respir Cell Mol Biol 2008; 39: 243-251.
26. Pinney SE, Jaeckle Santos LJ, Han Y, Stoffers DA, Simmons RA. Exendin-4 increases histone acetylase activity and reverses epigenetic modifications that silence Pdx1 in the intrauterine growth retarded rat. Diabetologia 2011; 54: 2606-2614.
27. Adachi T, Teramachi M, Yasuda H, Kamiya T, Hara H. Contribution of p38 MAPK, NF-κB and glucocorticoid signaling pathways to ER stress-induced increase in retinal endothelial permeability. Arch Biochem Biophys 2012; 520: 30-35.
28. Skoglund G, Hussain MA, Holz GG. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element. Diabetes 2000; 49: 1156-1164.
29. Mohan KN, Chaillet JR. Cell and molecular biology of DNA methyltransferase 1. Int Rev Cell Mol Biol 2013; 306: 1-42.
30. Ghoshal K, Datta J, Majumder S, et al. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Mol Cell Biol 2005; 25: 4727-4741.
31. Zelko IN, Folz RJ. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase. Free Radic Biol Med 2004; 37: 1256-1271.
32. Kamiya T, Machiura M, Makino J, Hara H, Hozumi I, Adachi T. Epigenetic regulation of extracellular-superoxide dismutase in human monocytes. Free Radic Biol Med 2013; 61: 197-205.